German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

German science and technology giant Merck on Thursday said it is confident of returning to medium-term growth after a ...

German science and technology company Merck lowered mid-term targets for its Life Sciences and Healthcare businesses, ...

British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of ...

Starting in the spring of 2025, Mountain Dew will be getting a new logo, which harkens back to classic branding with an ...

the Instituto de Salud Carlos III, the Merck Foundation and the International Josep Carreras Foundation. No generative AI tools have been used in the production of this manuscript.

Spelling out the word mountain is a "direct link to the origins of the brand, which is the mountains and the outdoors," said ...

The major U.S. index futures are currently pointing to a lower open on Thursday, with stocks likely to give back ground following the ...

Arcus Biosciences (RCUS) has received a new Buy rating, initiated by Wells Fargo analyst, Eva Fortea Verdejo. Eva Fortea Verdejo’s rating ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its third-quarter 2024 sales and earnings conference call with institutional ...

It spiked after the company released late-stage trial data showing one of its drugs, Ivonescimab, performed better than Merck's blockbuster Keytruda medication in some lung cancer patients.

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...